IP Library Patent Application 12356171
Patent Application
App. No. 12/356,171

BIOABSORBABLE BLOCK COPOLYMER

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/356,171
Abstract

A bioabsorbable polyurethane block copolymer with having hard and soft segments is formed by the reaction between a diisocyanate such as lysine ethyl ester diisocyanate and a mixture of (i) an aromatic amide or an amino acid derivative and (ii) a polyether glycol and/or an absorbable elastomeric polymer derived from the reaction between dialkylene glycol and a cyclic bioabsorbable monomer such as trimethylene carbonate, caprolactone, or dioxanone.

Claims (32)

1 . A bioabsorbable block copolymer possessing hard and soft segments comprising the reaction product of:

a) a biodegradable and biocompatible diisocyanate; and

b) a mixture of

i) an aromatic compound having molecular formula (I):

wherein X is oxygen or sulfur, and Z is selected from the group consisting of an alkyl moiety having from 1 to about 6 carbon atoms, an aralkyl moiety having from 7 to about 12 carbon atoms, a moiety having molecular formula (II):

a moiety having molecular formula (III):

and a moiety having molecular formula (IV):

—R 3 —CH(NHR 5 )—C(O)O—R 4 —  (IV)

wherein R 1 , R 2 , R 3 , and R 4 are independently selected from the group consisting of an alkyl moiety having from 1 to about 6 carbon atoms and an aralkyl group having from 7 to about 10 carbon atoms, R 5 is hydrogen or an alkyl group having from 1 to about 6 carbon atoms, and R 6 is an alkyl group of from about 1 to about 18 carbon atoms; and

ii) an aliphatic polyether glycol and/or an absorbable elastomeric polymer derived from the reaction between dialkylene glycol and a cyclic bioabsorbable monomer including at least one of trimethylene carbonate, dioxanone or caprolactone.

2 . The bioabsorbable block copolymer of claim 1 wherein the biodegradable and biocompatible diisocyanate is a lysine derivative.

3 . The bioabsorbable block copolymer of claim 2 wherein the lysine derivative is lysine ethyl ester diisocyanate.

4 . The bioabsorbable block copolymer of claim 1 wherein R 1 and R 2 are each —CH 2 CH 2 —.

5 . The bioabsorbable block copolymer of claim 1 wherein the polyalkylene glycol is selected from the group consisting of polyethylene glycol and polypropylene glycol.

6 . The bioabsorbable block copolymer of claim 1 wherein the absorbable elastomeric polymer is derived from the reaction between diethylene glycol and trimethylene carbonate.

7 . The bioabsorbable block copolymer of claim 1 further containing a medically useful substance selected from the group consisting of antimicrobial agents and tissue growth promoters.

8 . A surgical device fabricated from the block copolymer of claim 1 .

9 . The surgical device of claim 8 wherein the surgical device is selected from the group consisting of a surgical suture, a bone pin, a surgical clip and a two-part surgical fastener.

10 . A bioabsorbable block copolymer possessing alternating hard and soft segments comprising the reaction product of:

a) a biodegradable and biocompatible diisocyanate; and

b) a mixture of

i) an amino acid derivative having molecular formula (V):

H-[—X—R 7 —CH(NHR 8 )—C(O)-] n —X—R 7 —CH(NHR 8 )—C(O)—Y—R 9 —OH  (V)

wherein X is oxygen or sulfur, R 7 and R 9 are independently selected from an alkyl moiety having from 1 to about 6 carbon atoms, aryl, or alkaryl having from 7 to about 12 carbon atoms; R 8 is hydrogen or an alkyl moiety having from 1 to about 6 carbon atoms, Y is oxygen or —NH—, and n is an integer of from 1 to about 10; and

ii) an aliphatic polyether glycol and/or an absorbable elastomeric polymer derived from the reaction between dialkylene glycol and a cyclic bioabsorbable monomer including at least one of trimethylene carbonate, dioxanone or caprolactone.

11 . The bioabsorbable block copolymer of claim 10 wherein the biodegradable and biocompatible diisocyanate is a lysine derivative.

12 . The bioabsorbable block copolymer of claim 11 wherein the lysine derivative is lysine ethyl ester diisocyanate.

13 . The bioabsorbable block copolymer of claim 10 wherein the polyalkylene glycol is selected from the group consisting of polyethylene glycol and polypropylene glycol.

14 . The bioabsorbable block copolymer of claim 10 wherein the absorbable elastomeric polymer is derived from the reaction between diethylene glycol and trimethylene carbonate.

15 . The bioabsorbable block copolymer of claim 10 further containing a medically useful substance selected from the group consisting of antimicrobial agents and tissue growth promoters.

16 . A surgical device fabricated from the block copolymer of claim 10 .

17 . The surgical device of claim 16 wherein the surgical device is selected from the group consisting of a surgical suture, a bone pin, a surgical clip and a two-part surgical fastener.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2014
From: CONFLUENT SURGICAL, INC.
To: COVIDIEN LP
Reel/Frame 031957/0193 →
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2012
From: BENNETT, STEVEN L.
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 028284/0806 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2012
From: CONFLUENT SURGICAL, INC.
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 028284/0824 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2009
From: BENNETT, STEVEN L
To: CONFLUENT SURGICAL, INC.
Reel/Frame 022126/0921 →